Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
SIGN UP
SIGN IN
ENTITY
Insulet Corp (PODD US)
Watchlist
84
Analysis
Health Care
•
United States
Insulet Corporation is a medical device company that develops, manufactures and markets an insulin infusion system for people with insulin-dependent diabetes.
more
Watchlist
All
Insights
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bearish
•
Eoflow
•
09 Aug 2023 12:29
Insulet Accuses EOFlow Of Stealing Trade Secrets
EOFlow is trading at an 11.5% gross spread to terms. The downside to the unaffected price is 6.9%. But that downside factors in future earnings in...
David Blennerhassett
Follow
489 Views
Share
bearish
•
Eoflow
•
08 Aug 2023 23:54
EOFLOW/Medtronic Tender: Insulet’s US Complaint Materially Increases Deal Break Risks
The most likely scenarios are that Medtronic and Insulet sign a licensing agreement (resulting in a possible price cut) or Medtronic walks. Both...
Arun George
Follow
897 Views
Share
bullish
•
Eoflow
•
27 Jul 2023 15:21
EOFLOW/Medtronic Tender: Assessing the Wide Spread
Our assessment of the key deal risks suggests a low probability of a deal break. At the last close, the gross spread is an attractive 8.5%.
Arun George
Follow
406 Views
Share
bullish
•
Insulet Corp
•
26 Jul 2023 22:12
Insulet Corp (PODD US): Slow Recovery Is Expected on Easing Competition Fear; 2023 Guidance Raised
With 100K+ US customers for Omnipod 5, Insulet is ready to face additional competition in patch pump market. 2023 is going to be eighth consecutive...
Tina Banerjee
Follow
250 Views
Share
bullish
•
Eoflow
•
25 Jul 2023 22:00
An Update on Medtronic's Tender Offer of Eoflow
In this insight, we provide an update of Medtronic's tender offer of Eoflow. We continue to believe there is 95%+ probability of this M&A getting...
Douglas Kim
Follow
427 Views
Share
First
Previous
9
10
11
12
13
14
15
Next
Last
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.34.5
x